Abstract
Background: Atrial fibrillation (AF) is the most common dysrhythmia encountered in the post-coronary artery bypass (post-CABG) patient, reported to occur with a frequency of 20–40%. To date, with the exception of amiodarone, there is no evidence that prophylactic therapy or therapy to restore and maintain sinus rhythm reduces the risk of adverse events associated with AF. Objective: To determine whether rate control alone is an effective method of managing post-CABG AF. Method: Prospective nonrandomized observational pilot study to assess the outcome of patients with post-CABG AF managed with rate control (group 1) or a combination of rate control and sinus-restoring therapy (group 2). Adverse events, postoperative length of stay, and persistence of AF were assessed in both groups at discharge and 30 days post-discharge. Results: Post-CABG AF was observed in 101 patients. Among the 39 patients in group 1 and 62 patients in group 2, there was an 87% spontaneous conversion rate to sinus rhythm at discharge (p = 0.99). The surgical length of stay was 6.3 days in group 1, and 8.3 days in group 2 (p = 0.01). Adverse events were observed in 2 patients (5.1%) in group 1, and 7 patients (11.3%) in group 2 (p = 0.29). Conclusion: Rate control appears to be an effective method of management of post-CABG AF patients, reducing length of hospital stay without increasing the rate of adverse events. Similar proportions of patients from both groups were in sinus rhythm at time of discharge, irrespective of therapeutic techniques.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.